Twist Bioscience Corporation TWST Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's financing cash flow?
- Twist Bioscience Corporation (TWST) reported financing cash flow of $4.14M in Q1 2026.
- How has Twist Bioscience Corporation's financing cash flow changed year-over-year?
- Twist Bioscience Corporation's financing cash flow increased by 29.5% year-over-year, from $3.2M to $4.14M.
- What is the long-term trend for Twist Bioscience Corporation's financing cash flow?
- Over 3 years (2021 to 2025), Twist Bioscience Corporation's financing cash flow has grown at a -55.8% compound annual growth rate (CAGR), from $329.95M to $28.54M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.